NeoGenomics, Inc.
NeoGenomics, Inc. logo
NEO

NeoGenomics, Inc. (NEO)

$102.53%

Live
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$9.82
Day's Range
$10.31
$6.0
52-Week Range
$38.17
1 month return36.98%
3 month return0.49%
1 year return70.93%
5 year return12.75%

Company Information

NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company's Pharma Services division serves pharmaceutical clients in clinical trials and drug development. Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories in Ft. Myers and Tampa, Florida; Aliso Viejo, Carlsbad and Fresno California; Houston, Texas; Atlanta, Georgia; Nashville, Tennessee; Rolle, Switzerland, and Singapore. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia.
OrganizationNeoGenomics, Inc.
Employees2000
CEOMr. George A. Cardoza
IndustryHealth Services

Analyst Recommendation

based on 12 analysts ratings

Buy
91%
Buy
8%
Hold
0%
Sell

Based on 12 Wall street analysts offering stock ratings for NeoGenomics, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 61.1%

Current

$10.0

Target

$16.11

Recommendation Trend

Based on 12 analyst

Current1M Ago3M Ago
Buy
11
10
13
Hold
1
7
4
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
1.3B
Book Value
$8.0
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.29
PEG Ratio
3.02
Wall Street Target Price
16.11

Valuation

Trailing PE0.0
Forward PE222.22
Price/Book (mrq)
1.27
Enterprise Value
1.5B
Enterprise Value/Revenue
2.92
Enterprise Value/Ebitda
-13.74

Technicals

Beta
0.9
50 Day MA
8.64
200 Day MA
11.08

Institutional Holdings

Vanguard Group Inc

10.52%

Wellington Management Company LLP

5.15%

HHG PLC

4.71%

Brown Advisory Holdings Inc

4.4%

State Street Corporation

3.24%

Goldman Sachs Group Inc

2.7%

Discover more

Frequently Asked Questions

What is NeoGenomics, Inc. share price today?

Can Indians buy NeoGenomics, Inc. shares?

How can I buy NeoGenomics, Inc. shares from India?

Can Fractional shares of NeoGenomics, Inc. be purchased?

What are the documents required to start investing in NeoGenomics, Inc. stocks?

What are today’s High and Low prices of NeoGenomics, Inc.?

What are today’s traded volumes of NeoGenomics, Inc.?

What is today’s market capitalisation of NeoGenomics, Inc.?

What is the 52 Week High and Low Range of NeoGenomics, Inc.?

How much percentage NeoGenomics, Inc. is down from its 52 Week High?

How much percentage NeoGenomics, Inc. is up from its 52 Week low?

What are the historical returns of NeoGenomics, Inc.?

Who is the Chief Executive Officer (CEO) of NeoGenomics, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*